학술논문
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Document Type
article
Author
Anahita Fathi; Christine Dahlke; Verena Krähling; Alexandra Kupke; Nisreen M. A. Okba; Matthijs P. Raadsen; Jasmin Heidepriem; Marcel A. Müller; Grigori Paris; Susan Lassen; Michael Klüver; Asisa Volz; Till Koch; My L. Ly; Monika Friedrich; Robert Fux; Alina Tscherne; Georgia Kalodimou; Stefan Schmiedel; Victor M. Corman; Thomas Hesterkamp; Christian Drosten; Felix F. Loeffler; Bart L. Haagmans; Gerd Sutter; Stephan Becker; Marylyn M. Addo
Source
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Subject
Language
English
ISSN
2041-1723
Abstract
In a clinical trial, Fathi et al. show that a booster vaccination with a vector vaccine candidate against the highly pathogenic Middle East Respiratory Syndrome coronavirus is safe and strongly improves the immunity generated by primary immunization.